Axxion S.A.’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.67M Buy
10,189
+479
+5% +$123K 0.18% 98
2026
Q2
$2.44M Buy
+9,710
New +$2.09M 0.17% 104

Other funds holding ABBV

Axxion S.A.'s ABBV Position: Q3 2026 in Review

Axxion S.A. increased its AbbVie (ABBV) stake by 4.9% in Q3 2026, buying an estimated $123K and bringing the position to 10,189 shares worth $2.67M. The position accounts for 0.18% of the portfolio, ranked #98.

Axxion S.A. first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,250 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Axxion S.A. held 10,189 shares of AbbVie worth $2.67M as of Q3 2026.
  • Axxion S.A. bought 479 AbbVie shares in Q3 2026, an estimated $123K.
  • AbbVie made up 0.18% of Axxion S.A.'s portfolio in Q3 2026, its #98 holding.
  • Axxion S.A. first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,250 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.